175 related articles for article (PubMed ID: 30380416)
1. TRPS1 Is a Lineage-Specific Transcriptional Dependency in Breast Cancer.
Witwicki RM; Ekram MB; Qiu X; Janiszewska M; Shu S; Kwon M; Trinh A; Frias E; Ramadan N; Hoffman G; Yu K; Xie Y; McAllister G; McDonald R; Golji J; Schlabach M; deWeck A; Keen N; Chan HM; Ruddy D; Rejtar T; Sovath S; Silver S; Sellers WR; Jagani Z; Hogarty MD; Roberts C; Brown M; Stegmaier K; Long H; Shivdasani RA; Pellman D; Polyak K
Cell Rep; 2018 Oct; 25(5):1255-1267.e5. PubMed ID: 30380416
[TBL] [Abstract][Full Text] [Related]
2. TRPS1 regulates oestrogen receptor binding and histone acetylation at enhancers.
Serandour AA; Mohammed H; Miremadi A; Mulder KW; Carroll JS
Oncogene; 2018 Sep; 37(39):5281-5291. PubMed ID: 29895970
[TBL] [Abstract][Full Text] [Related]
3. TRPS1 drives heterochromatic origin refiring and cancer genome evolution.
Yang J; Liu X; Huang Y; He L; Zhang W; Ren J; Wang Y; Wu J; Wu X; Shan L; Yang X; Sun L; Liang J; Zhang Y; Shang Y
Cell Rep; 2021 Mar; 34(10):108814. PubMed ID: 33691114
[TBL] [Abstract][Full Text] [Related]
4. TRPS1 shapes YAP/TEAD-dependent transcription in breast cancer cells.
Elster D; Tollot M; Schlegelmilch K; Ori A; Rosenwald A; Sahai E; von Eyss B
Nat Commun; 2018 Aug; 9(1):3115. PubMed ID: 30082728
[TBL] [Abstract][Full Text] [Related]
5. Nuclear cathepsin D enhances TRPS1 transcriptional repressor function to regulate cell cycle progression and transformation in human breast cancer cells.
Bach AS; Derocq D; Laurent-Matha V; Montcourrier P; Sebti S; Orsetti B; Theillet C; Gongora C; Pattingre S; Ibing E; Roger P; Linares LK; Reinheckel T; Meurice G; Kaiser FJ; Gespach C; Liaudet-Coopman E
Oncotarget; 2015 Sep; 6(29):28084-103. PubMed ID: 26183398
[TBL] [Abstract][Full Text] [Related]
6. Tricho-rhino-phalangeal syndrome 1 protein functions as a scaffold required for ubiquitin-specific protease 4-directed histone deacetylase 2 de-ubiquitination and tumor growth.
Wang Y; Zhang J; Wu L; Liu W; Wei G; Gong X; Liu Y; Ma Z; Ma F; Thiery JP; Chen L
Breast Cancer Res; 2018 Aug; 20(1):83. PubMed ID: 30071870
[TBL] [Abstract][Full Text] [Related]
7. TRPS1 acts as a context-dependent regulator of mammary epithelial cell growth/differentiation and breast cancer development.
Cornelissen LM; Drenth AP; van der Burg E; de Bruijn R; Pritchard CEJ; Huijbers IJ; Zwart W; Jonkers J
Genes Dev; 2020 Feb; 34(3-4):179-193. PubMed ID: 31879358
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of TRPS1 stimulates epithelial-mesenchymal transition and metastasis through repression of FOXA1.
Huang JZ; Chen M; Zeng M; Xu SH; Zou FY; Chen D; Yan GR
J Pathol; 2016 Jun; 239(2):186-96. PubMed ID: 26969828
[TBL] [Abstract][Full Text] [Related]
9. A central role for TRPS1 in the control of cell cycle and cancer development.
Wu L; Wang Y; Liu Y; Yu S; Xie H; Shi X; Qin S; Ma F; Tan TZ; Thiery JP; Chen L
Oncotarget; 2014 Sep; 5(17):7677-90. PubMed ID: 25277197
[TBL] [Abstract][Full Text] [Related]
10. SALL1 functions as a tumor suppressor in breast cancer by regulating cancer cell senescence and metastasis through the NuRD complex.
Ma C; Wang F; Han B; Zhong X; Si F; Ye J; Hsueh EC; Robbins L; Kiefer SM; Zhang Y; Hunborg P; Varvares MA; Rauchman M; Peng G
Mol Cancer; 2018 Apr; 17(1):78. PubMed ID: 29625565
[TBL] [Abstract][Full Text] [Related]
11. Zinc finger transcription factor CASZ1 interacts with histones, DNA repair proteins and recruits NuRD complex to regulate gene transcription.
Liu Z; Lam N; Thiele CJ
Oncotarget; 2015 Sep; 6(29):27628-40. PubMed ID: 26296975
[TBL] [Abstract][Full Text] [Related]
12. TRPS1 knockdown inhibits angiogenic vascular mimicry in human triple negative breast cancer cells.
Wu M; Sun X; Wang T; Zhang M; Li P
Clin Transl Oncol; 2022 Jan; 24(1):145-153. PubMed ID: 34216368
[TBL] [Abstract][Full Text] [Related]
13. Expression of miRNA-26b-5p and its target TRPS1 is associated with radiation exposure in post-Chernobyl breast cancer.
Wilke CM; Hess J; Klymenko SV; Chumak VV; Zakhartseva LM; Bakhanova EV; Feuchtinger A; Walch AK; Selmansberger M; Braselmann H; Schneider L; Pitea A; Steinhilber J; Fend F; Bösmüller HC; Zitzelsberger H; Unger K
Int J Cancer; 2018 Feb; 142(3):573-583. PubMed ID: 28944451
[TBL] [Abstract][Full Text] [Related]
14. Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14.
Li Q; Shi L; Gui B; Yu W; Wang J; Zhang D; Han X; Yao Z; Shang Y
Cancer Res; 2011 Nov; 71(21):6899-908. PubMed ID: 21937684
[TBL] [Abstract][Full Text] [Related]
15. Heat shock factor 1 represses estrogen-dependent transcription through association with MTA1.
Khaleque MA; Bharti A; Gong J; Gray PJ; Sachdev V; Ciocca DR; Stati A; Fanelli M; Calderwood SK
Oncogene; 2008 Mar; 27(13):1886-93. PubMed ID: 17922035
[TBL] [Abstract][Full Text] [Related]
16. TRPS1 Expression in Breast Carcinomas: Focusing on Metaplastic Breast Carcinomas.
Parkinson B; Chen W; Shen T; Parwani AV; Li Z
Am J Surg Pathol; 2022 Mar; 46(3):415-423. PubMed ID: 35175968
[TBL] [Abstract][Full Text] [Related]
17. Matrix Gla protein (MGP), GATA3, and TRPS1: a novel diagnostic panel to determine breast origin.
Du T; Pan L; Zheng C; Chen K; Yang Y; Chen J; Chao X; Li M; Lu J; Luo R; Zhang J; Wu Y; He J; Jiang D; Sun P
Breast Cancer Res; 2022 Oct; 24(1):70. PubMed ID: 36284362
[TBL] [Abstract][Full Text] [Related]
18. Trps1 is associated with the multidrug resistance of lung cancer cell by regulating MGMT gene expression.
Liu H; Liao Y; Tang M; Wu T; Tan D; Zhang S; Wang H
Cancer Med; 2018 May; 7(5):1921-1932. PubMed ID: 29601666
[TBL] [Abstract][Full Text] [Related]
19. Nuclear interaction of the dynein light chain LC8a with the TRPS1 transcription factor suppresses the transcriptional repression activity of TRPS1.
Kaiser FJ; Tavassoli K; Van den Bemd GJ; Chang GT; Horsthemke B; Möröy T; Lüdecke HJ
Hum Mol Genet; 2003 Jun; 12(11):1349-58. PubMed ID: 12761050
[TBL] [Abstract][Full Text] [Related]
20. GATA3 and TRPS1 are distinct biomarkers and prognostic factors in breast cancer: database mining for GATA family members in malignancies.
Lin HY; Zeng D; Liang YK; Wei XL; Chen CF
Oncotarget; 2017 May; 8(21):34750-34761. PubMed ID: 28423734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
